Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 26.75%10.88B | ---- | 1.15%8.58B | ---- | 44.94%8.49B | ---- | 16.79%5.85B | ---- | 46.33%5.01B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 36.99%-652.37M | ---- | -46.90%-1.04B | ---- | -28.87%-704.78M | ---- | -111.72%-546.88M | ---- | -8.35%-258.3M |
| Interest expense - adjustment | ---- | 64.45%635.6M | ---- | -51.75%386.5M | ---- | 30.86%801.08M | ---- | -15.65%612.17M | ---- | 74.01%725.75M |
| Attributable subsidiary (profit) loss | ---- | -154.26%-968.37M | ---- | 62.35%-380.86M | ---- | -126.12%-1.01B | ---- | -548.24%-447.42M | ---- | 56.72%-69.02M |
| Impairment and provisions: | ---- | 103.50%3.83B | ---- | -53.71%1.88B | ---- | 520.36%4.06B | ---- | 124.60%654.87M | ---- | 3,697.08%291.58M |
| -Impairmen of inventory (reversal) | ---- | 124.13%3.67B | ---- | -55.54%1.64B | ---- | 499.71%3.68B | ---- | 125.23%614.23M | ---- | 1,337.60%272.71M |
| -Impairment of trade receivables (reversal) | ---- | -28.33%92.75M | ---- | 125.91%129.42M | ---- | 138.24%57.29M | ---- | 42.55%24.05M | ---- | -2.15%16.87M |
| -Other impairments and provisions | ---- | -44.22%63.17M | ---- | -64.80%113.24M | ---- | 1,837.77%321.71M | ---- | 728.44%16.6M | ---- | -83.94%2M |
| Revaluation surplus: | ---- | 866.77%368.66M | ---- | 106.20%38.13M | ---- | -9.52%18.49M | ---- | 175.24%20.44M | ---- | -120.31%-27.17M |
| -Fair value of investment properties (increase) | ---- | 604.30%364.66M | ---- | 52.76%51.78M | ---- | 58.68%33.89M | ---- | 39.66%21.36M | ---- | 142.42%15.29M |
| -Other fair value changes | ---- | 129.32%4M | ---- | 11.41%-13.64M | ---- | -1,573.91%-15.4M | ---- | 97.83%-920K | ---- | -127.79%-42.46M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | -103.38%-925K | ---- | 159.73%27.39M | ---- | -316.14%-45.86M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | -99.65%97K | ---- | 296.05%27.39M | ---- | -334.80%-13.97M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---1.02M | ---- | ---- | ---- | --1.92M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -333.00%-33.8M |
| Depreciation and amortization: | ---- | -2.39%147.27M | ---- | 26.73%150.87M | ---- | 55.85%119.04M | ---- | 6.83%76.39M | ---- | 23.06%71.5M |
| -Amortization of intangible assets | ---- | -31.66%9.17M | ---- | 80.88%13.42M | ---- | 402.92%7.42M | ---- | --1.48M | ---- | ---- |
| Special items | ---- | 20.86%359.66M | ---- | 123.70%297.59M | ---- | 215.21%133.03M | ---- | --42.2M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 47.13%14.6B | ---- | -16.65%9.92B | ---- | 89.11%11.9B | ---- | 10.39%6.29B | ---- | 63.30%5.7B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 175.20%38.41B | ---- | 161.69%13.96B | ---- | 72.94%-22.63B | ---- | -138.33%-83.62B | ---- | -62.29%-35.08B |
| Accounts receivable (increase)decrease | ---- | -3,484.51%-4.68B | ---- | 105.38%138.28M | ---- | -23.02%-2.57B | ---- | -299.99%-2.09B | ---- | 125.64%1.04B |
| Accounts payable increase (decrease) | ---- | -221.47%-2.49B | ---- | 4.17%2.05B | ---- | -86.97%1.96B | ---- | 85.13%15.07B | ---- | 122.82%8.14B |
| prepayments (increase)decrease | ---- | 72.47%-1.06B | ---- | ---3.85B | ---- | ---- | ---- | 48.32%-1.12B | ---- | -344.45%-2.17B |
| Special items for working capital changes | ---- | -608.76%-36.36B | ---- | -62.93%7.15B | ---- | -75.14%19.27B | ---- | 169.08%77.53B | ---- | 29.26%28.81B |
| Cash from business operations | ---- | -71.29%8.43B | ---- | 269.51%29.36B | ---- | -34.16%7.94B | ---- | 87.28%12.07B | ---- | 97.87%6.44B |
| Other taxs | ---- | 5.12%-4.69B | ---- | -11.70%-4.94B | ---- | 4.38%-4.43B | ---- | -113.22%-4.63B | ---- | -7.98%-2.17B |
| Special items of business | 452.63%12.03B | ---- | -110.14%-3.41B | ---- | 331.42%33.64B | ---- | 30.42%-14.54B | ---- | -69.78%-20.89B | ---- |
| Net cash from operations | 452.63%12.03B | -84.69%3.74B | -110.14%-3.41B | 593.75%24.41B | 331.42%33.64B | -52.69%3.52B | 30.42%-14.54B | 74.11%7.44B | -69.78%-20.89B | 242.89%4.27B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -36.99%652.37M | ---- | 46.90%1.04B | ---- | 28.87%704.78M | ---- | 111.72%546.88M | ---- | 8.35%258.3M |
| Dividend received - investment | ---- | 1.66%361.59M | ---- | 236.48%355.67M | ---- | -47.85%105.7M | ---- | 4,897.07%202.68M | ---- | -62.87%4.06M |
| Loan receivable (increase) decrease | ---- | -44.25%1.31B | ---- | 211.25%2.35B | ---- | 22.25%-2.11B | ---- | -225.86%-2.71B | ---- | 180.16%2.16B |
| Purchase of fixed assets | ---- | -66.89%-209.06M | ---- | -66.41%-125.27M | ---- | -3.31%-75.28M | ---- | -32.88%-72.86M | ---- | -84.87%-54.83M |
| Purchase of intangible assets | ---- | 87.99%-7.96M | ---- | -969.34%-66.3M | ---- | -2,692.79%-6.2M | ---- | ---222K | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | -429.20%-610.35M | ---- | 267.96%185.41M | ---- | 410.78%50.39M |
| Acquisition of subsidiaries | ---- | -109.57%-41.5M | ---- | 317.24%433.63M | ---- | 49.43%-199.61M | ---- | -4,590.29%-394.74M | ---- | 227.66%8.79M |
| Recovery of cash from investments | ---- | -97.90%1M | ---- | -88.76%47.64M | ---- | 1,596.00%424M | ---- | -95.58%25M | ---- | 4,184.08%565.8M |
| Cash on investment | ---- | 89.26%-650.79M | ---- | -8.12%-6.06B | ---- | -28.08%-5.61B | ---- | -97.01%-4.38B | ---- | -5.47%-2.22B |
| Other items in the investment business | -1,633.36%-12.45B | -7.55%-6.86B | 108.40%811.87M | 29.09%-6.38B | -200.68%-9.66B | 35.19%-9B | 19.11%-3.21B | -236.92%-13.88B | -300.10%-3.97B | 48.48%-4.12B |
| Net cash from investment operations | -1,633.36%-12.45B | 35.24%-5.45B | 108.40%811.87M | 48.60%-8.41B | -200.68%-9.66B | 20.07%-16.37B | 19.11%-3.21B | -510.70%-20.48B | -300.10%-3.97B | 73.28%-3.35B |
| Net cash before financing | 83.94%-417.49M | -110.70%-1.71B | -110.84%-2.6B | 224.49%16B | 235.07%23.98B | 1.47%-12.85B | 28.61%-17.75B | -1,519.58%-13.04B | -140.95%-24.86B | 108.13%918.84M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 7.11%31.17B | ---- | -28.49%29.1B | ---- | -32.39%40.7B | ---- | -63.72%60.19B | ---- | 42.68%165.93B |
| Refund | ---- | 35.93%-26.58B | ---- | -28.05%-41.48B | ---- | 3.42%-32.4B | ---- | 78.35%-33.54B | ---- | -54.24%-154.92B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | 49.20%1.16B | ---- | --777.55M | ---- | ---- |
| Interest paid - financing | ---- | 57.01%-906.06M | ---- | 22.39%-2.11B | ---- | 8.01%-2.72B | ---- | -67.43%-2.95B | ---- | -114.13%-1.76B |
| Dividends paid - financing | ---- | -104.48%-1.78B | ---- | 18.33%-871.4M | ---- | -266.79%-1.07B | ---- | 75.07%-290.9M | ---- | -13.18%-1.17B |
| Absorb investment income | ---- | -42.60%10.37B | ---- | 23.75%18.07B | ---- | -12.95%14.6B | ---- | 77.56%16.77B | ---- | 24.33%9.44B |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 61.07%-778M | ---- | ---2B | ---- | ---- | ---- | -2,785.30%-3.4B |
| Other items of the financing business | 76.67%-529.19M | 47.78%-7.35B | 83.71%-2.27B | -192.77%-14.08B | -423.47%-13.93B | 47.99%-4.81B | -85.37%4.3B | -567.84%-9.25B | 263.23%29.43B | 151.48%1.98B |
| Net cash from financing operations | 76.67%-529.19M | 139.45%4.83B | 83.71%-2.27B | -191.43%-12.24B | -423.47%-13.93B | -57.68%13.39B | -85.37%4.3B | 96.81%31.64B | 263.23%29.43B | -10.84%16.07B |
| Effect of rate | -195.69%-4.09M | 254.18%9.7M | -90.24%4.27M | 63.61%-6.29M | 95.55%43.74M | -1,164.10%-17.28M | 1,027.02%22.37M | 114.22%1.62M | -188.16%-2.41M | -219.03%-11.42M |
| Net Cash | 80.55%-946.69M | -17.07%3.12B | -148.44%-4.87B | 599.57%3.76B | 174.75%10.05B | -97.11%537.17M | -394.56%-13.44B | 9.41%18.59B | 305.87%4.56B | 152.71%16.99B |
| Begining period cash | 6.12%54.25B | 7.92%51.12B | 7.92%51.12B | 1.11%47.37B | 1.11%47.37B | 65.81%46.85B | 65.81%46.85B | 172.04%28.25B | 172.04%28.25B | 183.37%10.39B |
| Cash at the end | 15.22%53.29B | 6.12%54.25B | -19.50%46.26B | 7.92%51.12B | 71.91%57.46B | 1.11%47.37B | 1.86%33.43B | 71.18%46.85B | 301.59%32.82B | 163.51%27.37B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.